SMi’s In-Vitro Diagnostics (IVD) will prepare you for the challenging times ahead and how to comply with regulatory requirements to ensure direct access to market ensuring the continued growing demand for use and innovation of IVDs over the next decade and beyond.Topics of discussion the latest update on the IVD regulation, the implementation of the Qualified Person (QP) as well as the increase in requirements for clinical evidence.